Bristol-Myers Squibb stock jumps on schizophrenia drug approval
Bristol-Myers Squibb shares rose in premarket trade on Friday after the Food and Drug Administration approved a schizophrenia ...
These Stocks Are Moving the Most Today: Costco, Bristol Myers, EchoStar, Cassava Sciences, Trump Media, and More
Fiscal fourth-quarter revenue at Costco misses analysts’ estimates, Bristol Myers surges after the FDA approves an oral ...
Forbes30m
Cobenfy Approval Brings 20% Upside To Bristol Myers Squibb Stock
29 August 2024, Bavaria, Munich: The logo of the pharmaceutical company Bristol-Myers Squibb, (BMS) ... [+] is seen on the ...
Bristol Myers gets FDA approval for Cobenfy to treat Schizophrenia
The US FDA has approved Bristol Myers Squibb’s oral medicine, Cobenfy, for treating schizophrenia in adults. This is the ...
Stocks to Watch Friday: Bristol Myers Squibb, EchoStar, Costco
Shares jumped 6% in premarket trading after the Food and Drug Administration approved a treatment for [schizophrenia patients]( ...
Biggest stock movers Friday: BB, BMY, and more
Stock futures dipped early Friday morning as investors geared up to closely monitor new personal spending and inflation data. These economic indicators could of ...
The Express Tribune50m
FDA gives nod to first 'game changer' schizophrenia drug after 30 years
Cobenfy is the first FDA-approved antipsychotic that targets cholinergic receptors instead of dopamine receptors.
Ukraine's Zelenskyy courts US support, meets Harris in Washington
The vice president on Thursday pledged to continue support to Ukraine as she and the Ukrainian president discussed his ...